4//SEC Filing
Jiao Jin-an 4
Accession 0001209191-22-033517
CIK 0001828673other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 4:16 PM ET
Size
11.2 KB
Accession
0001209191-22-033517
Insider Transaction Report
Form 4
Jiao Jin-an
VP of Development
Transactions
- Exercise/Conversion
Common Stock
2022-05-31$0.21/sh+1,714$360→ 45,141 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-05-31−12,856→ 18,001 totalExercise: $0.14Exp: 2029-05-29→ Common Stock (12,856 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2022-05-31−1,714→ 6,857 totalExercise: $0.21Exp: 2030-12-22→ Common Stock (1,714 underlying) - Exercise/Conversion
Common Stock
2022-05-31$0.14/sh+12,856$1,800→ 43,427 total
Footnotes (2)
- [F1]These option shares were part of a stock option grant covering 51,428 shares of common stock. 20% of the total shares subject to the stock option grant vested on May 30, 2020; 20% of the total shares subject to the stock option grant vested on May 30, 2021; 25% of the total shares subject to the stock option grant will vest on May 30, 2022; and 35% of the total shares subject to the stock option grant will vest on May 30, 2023.
- [F2]20% of the total shares subject to the stock option grant will vest on December 22, 2021; 20% of the total shares subject to the stock option grant will vest on December 22, 2022; 25% of the total shares subject to the stock option grant will vest on December 22, 2023; and 35% of the total shares subject to the stock option grant will vest on December 22, 2024.
Documents
Issuer
HCW Biologics Inc.
CIK 0001828673
Entity typeother
Related Parties
1- filerCIK 0001866271
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 4:16 PM ET
- Size
- 11.2 KB